ON-TREATMENT PREDICTION OF SUSTAINED RESPONSE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGYLATED INTERFERON ALFA-2A

Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline

Sonneveld, Milan
Rijckborst, Vincent
Boucher, Charles
Hansen, Bettina
Janssen, HLA

January 2010

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegyla...

Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline

Sonneveld, Milan
Rijckborst, Vincent
Boucher, Charles
Hansen, Bettina
Janssen, HLA

January 2010

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegyla...

Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

Güçlü, Ertuğrul
Nazan Tuna
Karabay, Oğuz
Sila Akhan
Hurrem Bodur
Bahadir Ceylan
Tuna Demirdal
Kutbettin Demirdag
Nese Demirturk
Ekerbiçer, Hasan Çetin
Serpil Erol
Esen, Sinan
Omer Evirgen
Mehmet Faruk Geyik
Alper Gunduz
Mustafa Kasim Karahocagil
Omer Faruk Kokoglu
Davut Ozdemir
Nail Ozgunes
Fatma Sargin
Selma Tosun
Ediz Tutuncu

January 2014

Introduction: Although pegylated interferons (pegIFNs) alpha-2a and alpha-2b have been used in chron...

ON-TREATMENT PREDICTION OF SUSTAINED RESPONSE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGYLATED INTERFERON ALFA-2A

Rijckborst, Vincent
Hansen, Bettina E.
Tabak, Fehmi
Raptopoulou-Gigi, Maria
Ormeci, Necati
Simon, Krzysztof
Akarca, Ulus S.
Flisiak, Robert
Vafiadis-Zouboulis, Irini
Tripi, Silvio
Verhey, Elke
ter Borg, Martijn
van Vuuren, Anneke J.
Janssen, Harry L.

January 2009

60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- OCT 30-NOV 03, 20...

On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

Goulis, I.
Karatapanis, S.
Akriviadis, E.
Deutsch, M.
Dalekos, G. N.
Raptopoulou-Gigi, M.
Mimidis, K.
Germanidis, G.
Drakoulis, C.
Triantos, C.
Zintzaras, E.
Bakalos, G.
Papatheodoridis, G.

January 2015

Background & AimsWe assessed predictors of response in HBeAg-negative chronic hepatitis B patients t...

Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels

Rijckborst, Vincent
Hansen, Bettina E.
Cakaloglu, Yilmaz
Ferenci, Peter
Tabak, Fehmi
Akdogan, Meral
Simon, Krzysztof
Akarca, Ulus S.
Flisiak, Robert
Verhey, Elke
Van Vuuren, Anneke J.
Boucher, Charles A. B.
ter Borg, Martijn J.
Janssen, Harry L. A.

January 2010

WOS: 000280513900008PubMed ID: 20683945Peginterferon alfa-2a results in a sustained response (SR) in...

First detailed analysis of predictors of response in HBeAg-negative chronic hepatitis B: Data from a multicenter, randomized, partially double-blind study of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine alone

Bonino, F.
Lau, G.
Macellin, P.
Hadziyannis, S.
Kitis, G.
Jin, R.
Yao, G.B.
Piratvisuth, T.
Germanidis, G.
Yurdaydın, Cihan
Diago, M.
Lai, M.
McCloud, P.
Brunetto, M.R.
Farci, P.

October 2004

Bu çalışma, 29 Ekim- 2 Kasım 2004 tarihleri arasında Boston[Amerika Birleşik Devletleri]'da düzenlen...

Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels

Rijckborst, Vincent
Hansen, Bettina
Cakaloglu, Y
Ferenci, P
Tabak, F
Akdogan, M
Simon, K
Akarca, US
Flisiak, R
Verheij-Hart, E
van Vuuren, Hanneke
Boucher, Charles
ter Borg, MJ (Martijn)
Janssen, HLA

January 2010

Peginterferon alfa-2a results in a sustained response (SR) in a minority of patients with hepathis B...

Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels

ter Borg, Martijn J.
Tabak, Fehmi
Boucher, Charles A. B.
Janssen, Harry L. A.
Cakaloglu, Yilmaz
Rijckborst, Vincent
Hansen, Bettina E.
Ferenci, Peter
Akdogan, Meral
Simon, Krzysztof
AKARCA, ULUS SALİH
Flisiak, Robert
Verhey, Elke
Van Vuuren, Anneke J.

January 2010

Peginterferon alfa-2a results in a sustained response (SR) in a minority of patients with hepathis B...

Response predictors to treatment with pegylated interferon in chronic hepatitis B

Paulo Roberto Abrão Ferreira
Simone de Barros Tenore

The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a ...

Response predictors to treatment with pegylated interferon in chronic hepatitis B

Abrão Ferreira, Paulo Roberto
Tenore, Simone de Barros

October 2010

AbstractThe clinical and epidemiological importance of chronic B hepatitis is currently unquestionab...

The Change of Quantitative of HBeAg Can Predict the Efficacy of Peg-IFN-α 2a in HBeAgpositive CHB Patients

Ji Yong-jian
Ren Wan-hua
Li Fei-fei
Fang Jian-ting
Sun Xi-zhen
Qin Cheng-yong

September 2013

Objective To investigate the quantitation of hepatitis B e antigen (HBeAg) at week 24 in predicting ...

Prediction of the Response to Peg-Interferon-Alfa in Patients With HBeAg Positive Chronic Hepatitis B Using Decline of HBV DNA During Treatment

Hansen, Bettina
Buster, Erik
Steyerberg, Ewout
Lesaffre, Emmanuel
Janssen, HLA

January 2010

Peginterferon (PEG-IFN) results in HBeAg loss combined with virologic response in only a minority of...

On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))

Farci, Patrizia
Marcellin, Patrick
Lu, Zhi-Meng
Diago, Moises
Lai, Ming-Yang
Kittis, G
Yurdaydin, Cihan
Zahm, FE
Bonino, FD

April 2005

Bu çalışma, 13-17 Nisan 2005 tarihleri arasında Paris'te düzenlenen Avrupa Karaciğer Çalışmaları 40....

HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE

Sonneveld, Milan J.
Rijckborst, Vincent
Senturk, Hakan
Zeuzem, Stefan
Akarca, Ulus S.
Simon, Krzysztof
Gerken, Guido
Boucher, Charles A.
Hansen, Bettina E.
Janssen, Harry L.

January 2010

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- OCT 29-NOV 02, 20...

Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline

Sonneveld, Milan
Rijckborst, Vincent
Boucher, Charles
Hansen, Bettina
Janssen, HLA

January 2010

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegyla...

Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline

Sonneveld, Milan
Rijckborst, Vincent
Boucher, Charles
Hansen, Bettina
Janssen, HLA

January 2010

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegyla...

Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

Güçlü, Ertuğrul
Nazan Tuna
Karabay, Oğuz
Sila Akhan
Hurrem Bodur
Bahadir Ceylan
Tuna Demirdal
Kutbettin Demirdag
Nese Demirturk
Ekerbiçer, Hasan Çetin
Serpil Erol
Esen, Sinan
Omer Evirgen
Mehmet Faruk Geyik
Alper Gunduz
Mustafa Kasim Karahocagil
Omer Faruk Kokoglu
Davut Ozdemir
Nail Ozgunes
Fatma Sargin
Selma Tosun
Ediz Tutuncu

January 2014

Introduction: Although pegylated interferons (pegIFNs) alpha-2a and alpha-2b have been used in chron...

ON-TREATMENT PREDICTION OF SUSTAINED RESPONSE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGYLATED INTERFERON ALFA-2A

Rijckborst, Vincent
Hansen, Bettina E.
Tabak, Fehmi
Raptopoulou-Gigi, Maria
Ormeci, Necati
Simon, Krzysztof
Akarca, Ulus S.
Flisiak, Robert
Vafiadis-Zouboulis, Irini
Tripi, Silvio
Verhey, Elke
ter Borg, Martijn
van Vuuren, Anneke J.
Janssen, Harry L.

January 2009

60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- OCT 30-NOV 03, 20...

On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

Goulis, I.
Karatapanis, S.
Akriviadis, E.
Deutsch, M.
Dalekos, G. N.
Raptopoulou-Gigi, M.
Mimidis, K.
Germanidis, G.
Drakoulis, C.
Triantos, C.
Zintzaras, E.
Bakalos, G.
Papatheodoridis, G.

January 2015

Background & AimsWe assessed predictors of response in HBeAg-negative chronic hepatitis B patients t...

Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels

Rijckborst, Vincent
Hansen, Bettina E.
Cakaloglu, Yilmaz
Ferenci, Peter
Tabak, Fehmi
Akdogan, Meral
Simon, Krzysztof
Akarca, Ulus S.
Flisiak, Robert
Verhey, Elke
Van Vuuren, Anneke J.
Boucher, Charles A. B.
ter Borg, Martijn J.
Janssen, Harry L. A.

January 2010

WOS: 000280513900008PubMed ID: 20683945Peginterferon alfa-2a results in a sustained response (SR) in...

First detailed analysis of predictors of response in HBeAg-negative chronic hepatitis B: Data from a multicenter, randomized, partially double-blind study of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine alone

Bonino, F.
Lau, G.
Macellin, P.
Hadziyannis, S.
Kitis, G.
Jin, R.
Yao, G.B.
Piratvisuth, T.
Germanidis, G.
Yurdaydın, Cihan
Diago, M.
Lai, M.
McCloud, P.
Brunetto, M.R.
Farci, P.

October 2004

Bu çalışma, 29 Ekim- 2 Kasım 2004 tarihleri arasında Boston[Amerika Birleşik Devletleri]'da düzenlen...

Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels

Rijckborst, Vincent
Hansen, Bettina
Cakaloglu, Y
Ferenci, P
Tabak, F
Akdogan, M
Simon, K
Akarca, US
Flisiak, R
Verheij-Hart, E
van Vuuren, Hanneke
Boucher, Charles
ter Borg, MJ (Martijn)
Janssen, HLA

January 2010

Peginterferon alfa-2a results in a sustained response (SR) in a minority of patients with hepathis B...

Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels

ter Borg, Martijn J.
Tabak, Fehmi
Boucher, Charles A. B.
Janssen, Harry L. A.
Cakaloglu, Yilmaz
Rijckborst, Vincent
Hansen, Bettina E.
Ferenci, Peter
Akdogan, Meral
Simon, Krzysztof
AKARCA, ULUS SALİH
Flisiak, Robert
Verhey, Elke
Van Vuuren, Anneke J.

January 2010

Peginterferon alfa-2a results in a sustained response (SR) in a minority of patients with hepathis B...

Response predictors to treatment with pegylated interferon in chronic hepatitis B

Paulo Roberto Abrão Ferreira
Simone de Barros Tenore

The clinical and epidemiological importance of chronic B hepatitis is currently unquestionable as a ...

Response predictors to treatment with pegylated interferon in chronic hepatitis B

Abrão Ferreira, Paulo Roberto
Tenore, Simone de Barros

October 2010

AbstractThe clinical and epidemiological importance of chronic B hepatitis is currently unquestionab...

The Change of Quantitative of HBeAg Can Predict the Efficacy of Peg-IFN-α 2a in HBeAgpositive CHB Patients

Ji Yong-jian
Ren Wan-hua
Li Fei-fei
Fang Jian-ting
Sun Xi-zhen
Qin Cheng-yong

September 2013

Objective To investigate the quantitation of hepatitis B e antigen (HBeAg) at week 24 in predicting ...

Prediction of the Response to Peg-Interferon-Alfa in Patients With HBeAg Positive Chronic Hepatitis B Using Decline of HBV DNA During Treatment

Hansen, Bettina
Buster, Erik
Steyerberg, Ewout
Lesaffre, Emmanuel
Janssen, HLA

January 2010

Peginterferon (PEG-IFN) results in HBeAg loss combined with virologic response in only a minority of...

On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))

Farci, Patrizia
Marcellin, Patrick
Lu, Zhi-Meng
Diago, Moises
Lai, Ming-Yang
Kittis, G
Yurdaydin, Cihan
Zahm, FE
Bonino, FD

April 2005

Bu çalışma, 13-17 Nisan 2005 tarihleri arasında Paris'te düzenlenen Avrupa Karaciğer Çalışmaları 40....

HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE

Sonneveld, Milan J.
Rijckborst, Vincent
Senturk, Hakan
Zeuzem, Stefan
Akarca, Ulus S.
Simon, Krzysztof
Gerken, Guido
Boucher, Charles A.
Hansen, Bettina E.
Janssen, Harry L.

January 2010

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- OCT 29-NOV 02, 20...

Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline

Sonneveld, Milan
Rijckborst, Vincent
Boucher, Charles
Hansen, Bettina
Janssen, HLA

January 2010

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegyla...

Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline

Sonneveld, Milan
Rijckborst, Vincent
Boucher, Charles
Hansen, Bettina
Janssen, HLA

January 2010

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegyla...

Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

Güçlü, Ertuğrul
Nazan Tuna
Karabay, Oğuz
Sila Akhan
Hurrem Bodur
Bahadir Ceylan
Tuna Demirdal
Kutbettin Demirdag
Nese Demirturk
Ekerbiçer, Hasan Çetin
Serpil Erol
Esen, Sinan
Omer Evirgen
Mehmet Faruk Geyik
Alper Gunduz
Mustafa Kasim Karahocagil
Omer Faruk Kokoglu
Davut Ozdemir
Nail Ozgunes
Fatma Sargin
Selma Tosun
Ediz Tutuncu

January 2014

Introduction: Although pegylated interferons (pegIFNs) alpha-2a and alpha-2b have been used in chron...

ON-TREATMENT PREDICTION OF SUSTAINED RESPONSE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGYLATED INTERFERON ALFA-2A

Abstract

Extracted data

ON-TREATMENT PREDICTION OF SUSTAINED RESPONSE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGYLATED INTERFERON ALFA-2A

Abstract

Extracted data

Related items

Related items